Anxin Gu

571 total citations
14 papers, 433 citations indexed

About

Anxin Gu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anxin Gu has authored 14 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anxin Gu's work include Virus-based gene therapy research (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and RNA Interference and Gene Delivery (2 papers). Anxin Gu is often cited by papers focused on Virus-based gene therapy research (2 papers), Sirtuins and Resveratrol in Medicine (2 papers) and RNA Interference and Gene Delivery (2 papers). Anxin Gu collaborates with scholars based in China and United States. Anxin Gu's co-authors include E Mingyan, Feng‐Ming Kong, Mitchell Machtay, Weili Wang, Jian‐Yue Jin, Nancy L. Oleinick, Liyuan Guo, Yan Peng, Qiang Yao and Sui Li-hua and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Anxin Gu

14 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anxin Gu China 10 151 125 102 85 73 14 433
María José Ruiz-Magaña Spain 11 234 1.5× 43 0.3× 78 0.8× 29 0.3× 39 0.5× 23 506
John Akudugu South Africa 13 138 0.9× 113 0.9× 88 0.9× 44 0.5× 138 1.9× 52 363
Anwen Liu China 13 276 1.8× 97 0.8× 104 1.0× 43 0.5× 33 0.5× 26 550
Jiawen Dai China 6 180 1.2× 155 1.2× 173 1.7× 37 0.4× 126 1.7× 7 547
Salomé Paillas France 13 229 1.5× 152 1.2× 135 1.3× 51 0.6× 221 3.0× 15 517
Xixu Zhu China 13 192 1.3× 233 1.9× 114 1.1× 62 0.7× 137 1.9× 31 544
Shigeaki Sunada Japan 11 219 1.5× 102 0.8× 100 1.0× 22 0.3× 57 0.8× 19 341
Sami Benzina France 11 221 1.5× 34 0.3× 62 0.6× 10 0.1× 16 0.2× 17 341
Yongshun Chen China 10 119 0.8× 187 1.5× 148 1.5× 34 0.4× 36 0.5× 20 384

Countries citing papers authored by Anxin Gu

Since Specialization
Citations

This map shows the geographic impact of Anxin Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anxin Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anxin Gu more than expected).

Fields of papers citing papers by Anxin Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anxin Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anxin Gu. The network helps show where Anxin Gu may publish in the future.

Co-authorship network of co-authors of Anxin Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Anxin Gu. A scholar is included among the top collaborators of Anxin Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anxin Gu. Anxin Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Lin, Quan, et al.. (2024). Tricetin attenuates atherosclerosis by suppressing macrophage ferroptosis via activation of the NRF2 pathway. International Immunopharmacology. 143(Pt 2). 113418–113418. 3 indexed citations
2.
Meng, Chi, Ying Li, Duo Wang, et al.. (2023). Novel structured ADAM17 small-molecule inhibitor represses ADAM17/Notch pathway activation and the NSCLC cells’ resistance to anti-tumour drugs. Frontiers in Pharmacology. 14. 1189245–1189245. 4 indexed citations
3.
Zhuang, Ming, Shan Jiang, Anxin Gu, Xuesong Chen, & E Mingyan. (2021). Radiosensitizing effect of gold nanoparticle loaded with small interfering RNA-SP1 on lung cancer. Translational Oncology. 14(12). 101210–101210. 15 indexed citations
4.
Liu, Guijun, E Mingyan, Ying Li, et al.. (2021). Novel small molecule inhibitors of the transcription factor ETS-1 and their antitumor activity against hepatocellular carcinoma. European Journal of Pharmacology. 906. 174214–174214. 23 indexed citations
5.
Liu, Guijun, Lina Feng, Ying Li, et al.. (2021). PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies. Frontiers in Immunology. 12. 665970–665970. 43 indexed citations
6.
Jin, Jian‐Yue, Anxin Gu, Weili Wang, et al.. (2020). Ultra-high dose rate effect on circulating immune cells: A potential mechanism for FLASH effect?. Radiotherapy and Oncology. 149. 55–62. 124 indexed citations
7.
8.
9.
Liu, Guohui, Anxin Gu, & E Mingyan. (2020). [Mechanism and Research Progress of Microbiome in the Development of Lung Cancer].. SHILAP Revista de lepidopterología. 23(11). 948–953. 4 indexed citations
10.
Wang, Hongyan, Yan Peng, Jing Wang, et al.. (2018). Effect of autophagy on the resveratrol‐induced apoptosis of ovarian cancer SKOV3 cells. Journal of Cellular Biochemistry. 120(5). 7788–7793. 21 indexed citations
11.
Yao, Qiang, Anxin Gu, Zhuozhong Wang, & Yingwei Xue. (2018). MicroRNA-144 functions as a tumor suppressor in gastric cancer by targeting cyclooxygenase-2. Experimental and Therapeutic Medicine. 15(3). 3088–3095. 23 indexed citations
12.
Gu, Anxin, et al.. (2016). Slug Is Associated With Tumor Metastasis and Angiogenesis in Ovarian Cancer. Reproductive Sciences. 24(2). 291–299. 39 indexed citations
13.
Gu, Anxin, et al.. (2015). RhNRG-1β Protects the Myocardium against Irradiation-Induced Damage via the ErbB2-ERK-SIRT1 Signaling Pathway. PLoS ONE. 10(9). e0137337–e0137337. 22 indexed citations
14.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María José Ruiz-Magaña Breakdown of academic impact, for papers by John Akudugu Breakdown of academic impact, for papers by Anwen Liu Breakdown of academic impact, for papers by Jiawen Dai Breakdown of academic impact, for papers by Salomé Paillas Breakdown of academic impact, for papers by Xixu Zhu Breakdown of academic impact, for papers by Shigeaki Sunada Breakdown of academic impact, for papers by Sami Benzina Breakdown of academic impact, for papers by Yongshun Chen
Rankless by CCL
2026